Acquiring Cultural Competency:
53-y/o Russian immigrant with drug-resistant tuberculosis (Web-based video)
To receive CME credit for participating in this activity, click here before viewing this case.
If you do not wish to receive CME credit, select one of the options below to best view the case.
- high bandwidth (1Mbit LAN & T1)
- medium bandwidth (512k DSL)
- low bandwidth (256k DSL)
- Assess the possibility that a patient's previous healthcare experiences in other societies may make it difficult for them to access US healthcare services.
- Review the importance of obtaining a trained medical interpreter to facilitate effective communication with your patient and provide good care.
- Incorporate clinical and communication tools and competencies to accommodate a patient's cultural and social context when formulating treatment and management plans.
- To receive AMA PRA Category 1 Credit™, review the entire case, complete the post-test questions and submit the evaluation instrument.
- View, save or print your certificate.
Duration: Maximum of 1 hour
Credit: Up to 1 AMA PRA Category 1 Credit™
Fee: No feeOriginal Release Date: September 22, 2008
Last Review Date: September 22, 2008
Expiration Date: September 22, 2011There is no commercial support for this activity.
Program overview
Cultural competence is now recognized by various governmental and accreditation agencies as essential for improving patients' health status, providing access to health care and for eliminating disparities in health care delivery. This has included Association of American Medical Colleges (AAMC) Liaison Committee on Medical Education (LCME), Accreditation Council for Graduate Medical Education (ACGME) and The Department of Health and Human Services’ Office of Minority Health. Additionally, in 2005, New Jersey became the first state to require cultural competency training for physicians as a condition of licensure. More recently, Washington, California, New Mexico and Maryland have passed legislation mandating or strongly recommending cultural competency training.
The introduction of anti-tuberculosis medications in the late 1940’s was followed by a steady decline in the incidence of tuberculosis (TB) in the United States. However, beginning in the mid-1980’s there was a resurgence in the number of reported cases due to several factors including: (i) the deterioration of the TB public health infrastructure; (ii) the HIV/acquired immunodeficiency syndrome (AIDS) epidemic; (iii) immigration of persons from countries where TB was common; (iv) transmission of TB in congregate settings (e.g. prisons and long-term care and nursing facilities); and (v) emergence of multi-drug resistant (MDR) TB.
The management of TB has become even more challenging with the emergence of multiple drug resistant tuberculosis (MDR-TB). In the United States, factors that contribute to the development of MDR-TB include poor physician prescribing practices, erratic self-administration of drugs, poor infection control programs in hospitals and prisons, and poorly supervised treatment programs. The HIV/AIDS epidemic has facilitated the spread of MDR-TB by providing a large reservoir of immunosuppressed individuals who are at increased risk for developing an active, communicable disease following infection. MDR-TB is also is an important health issue in other countries such as the countries of the former Soviet Union.
The successful treatment of all diagnosed cases of TB is a major public health priority. Given the significant racial, ethnic and social dimensions to TB, it is clear that management of TB and the achievement of national health care goals in the eradication of this infection requires health care professionals who are able to provide cultural effective and sensitive care.
Intended audience
This activity has been designed for physicians in training (interns, residents and fellows), practicing physicians and is also applicable to all medical disciplines and specialties and medical students.
Learning objectives
Upon completion of this activity, participants should be better able to:
Accreditation
The University of Pennsylvania School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation of CreditThe University of Pennsylvania School of Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Format
Web-based interactive mixed media
Computer Requirements
Windows: Latest release of Safari, Internet Explorer 6/7 or Mozilla/Firefox.
Macintosh: Latest release of Safari or Mozilla/Firefox.
Plugins: Real PlayerCompletion Instructions
Faculty
Horace DeLisser, MD |
Ronald Collman, MD |
DisclosuresIt is policy at the University of Pennsylvania School of Medicine for individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest that provides products or services that may be relevant to the content of this continuing medical education activity.
The staff in the Office of CME at the University of Pennsylvania School of Medicine and the peer reviewer, Zalman Agus, MD, have reported no relevant financial relationships with any commercial interests related to the content of this educational activity.
The following faculty have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity:
Ronald Collman, MD; Horace DeLisser, MD; Lisa Hark, PhD, RD
Investigational and/or Off-Label Use of Commercial Products and Devices
The University of Pennsylvania School of Medicine requires all faculty to disclose any planned discussion of an investigational and/or off-label use of a pharmaceutical product or device within their presentation. Participants should note that the use of products outside FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for approved indications.The faculty members have reported that there will be no discussion of investigational and/or off-label use of commercial products within the activity.
Contact Information
For CME-related questions, please contact the University of Pennsylvania School of Medicine, Office of Continuing Medical Education, at penncme@mail.med.upenn.edu or at 215-898-9750.
Attention Educators:
Quiz your audience after teaching this case. CLICK HERE.CME Privacy Policy